Expert panel issues ‘weak’ recommendation for use of medical cannabis for chronic pain

摘要

An international expert panel has issued a “weak” recommendation to offer a trial of non-inhaled medical cannabis, or cannabinoids, for people with chronic pain, if standard care is not sucient. The BMJ rapid recommendation (https://www.bmj.com/content/374/bmj.n2040) , published on 9 September 2021, applies to adults and children living with moderate-to-severe chronic pain, regardless of pain mechanism, including cancer-related chronic pain. It aims to address the confusion around the role of medical cannabis in the management of chronic pain.